Verified email-pattern data for Evvivax is currently limited. You can still use the company insights and contact sections below.
EVVIVAX is a Biotech Company created in June 2016 as a spin off from Takis, a Biotech created by a group of scientists previously part of Merck Research Laboratories (MRL). EVVIVAX pursues the discovery and development of innovative Therapeutic Veterinary Cancer Vaccines based on a Adenoviral vector/DNA platform technology, leveraging on its strong track record in drug discovery.
EVVIVAX’ frontline candidates are two therapeutic cancer vaccines for canine tumors: a) Tel-eVax, targeting Telomerase (TERT), a key molecule in Oncology. b) Erb-eVax, against HER2/neu oncogene, a well-known and validated target in Oncology. The main cancer types suitable for these immunotherapies are: Lymphomas, Breast, Osteosarcoma and Tensitional cell carcinomas. EVVIVAX business strategy for the next 5 years is: 1) to develop Tel-eVax and Erb-eVax as marketed products in USA and then in Europe; 2) license out the products to Pharma/large Biotech companies, in exchange for upfront, success-based milestones and royalty fees. Other R&D projects are under advanced pre-clinical development. EVVIVAX aims at translating scientific breakthrough achievements in Cancer Immunotherapy into marketed innovative products in Veterinary and subsequently in Human Oncology.
Veterinary Oncology is an extraordinary growing market opportunity: one in every four dogs will develop cancer during its lifetime and this generally kills nearly half of pet dogs over the age ten. Cancer in canines is still predominantly treated through surgical excision, chemotherapy and radiation therapy, highly invasive procedures that can result in unpleasant side-effects. The economic benefit of EVVIVAX' products include access to a first-in class therapy (prolonged life expectation) at cost similar to current therapy and expenses reduction associated with reduced side-effects.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Via Castel Romano 100, Rome,rm 00128,italy
- in****@****vax.com
- Industry
- Veterinary Services
- Website
- evvivax.com
- HQ
- Rome, RM
Evvivax Questions
Evvivax's website is evvivax.com
Evvivax's LinkedIn profile is https://it.linkedin.com/company/evvivax
Evvivax has
3 employees.
View email and phone details for 3
employees at Evvivax.
Evvivax's industry is
Veterinary Services
Evvivax's top competitors are
4basebio,
Vitares,
Thermo Fisher Scientific,
Takis,
Egualia – Industrie Farmaci Accessibili,
Neomatrix,
Tecnopolo Roma,
Reithera,
Ab Analitica,
Exiris S.r.l..
Evvivax's support email address is info@evvivax.com
Evvivax's categories are Veterinary Services
Evvivax's founding year is 2016
Top Evvivax Employees
-
Monica Fraternali
Impiegato Amministrativo Presso Evvivax
Ariccia, Latium, Italy, Italy -
Luigi Aurisicchio
Ceo At Takis, Evvivax & Neomatrix |…
Rome, Latium, Italy, Italy2merck.com, takisbiotech.it
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.